Ebony A. Miller

University of Minnesota — United States

Medicine · Health Sciences

4h-index96citations28works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(18), Immune Cell Function and Interaction(15), CAR-T cell therapy research(13), Pancreatic and Hepatic Oncology Research(5), Phagocytosis and Immune Regulation(4)

Publications28 total

Immunotherapy promotes CD4 T cell effector function, limits Tregs, and relies on CD4 T cells to restrain excessive myeloid infiltration in a preclinical model of pancreatic cancer 2394
The Journal of Immunology·2025Open Access
IL-15 complex with agonistic anti-CD40 + anti-PDL1 overcomes T cell exhaustion and drives a T-bet+ effector program for pancreatic ductal adenocarcinoma eradication 3573
The Journal of Immunology·2025Open Access
Immunotherapy promotes tumor adapted TNF-producing neutrophils that impair T cell clonal expansion and resident memory formation in pancreatic ductal adenocarcinoma 2236
The Journal of Immunology·2025Open Access
Targeting Regulatory T cells controls metastatic pancreatic ductal adenocarcinoma by modulation of conventional CD4 T helper cells 3557
The Journal of Immunology·2025Open Access
Supplementary Figure 6 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 1 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Data from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025· 1 citedOpen Access
Supplementary Tables from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 3 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 7 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 2 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 9 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary FIgure 8 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 4 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 5 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma
Cancer Immunology Research·2025· 4 citedOpen Access
Abstract 5308: Ifngr1 signaling on tumor-specific CD4 T cells is required to mitigate Treg differentiation during CD40 agonist and anti-PD-L1 immunotherapy in pancreatic ductal adenocarcinoma
Cancer Research·2024
Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma
Cell Reports·2023· 46 citedOpen Access
Antigen-specific CD4 T cell polarization is altered by immune checkpoint blockade in pancreatic ductal adenocarcinoma
The Journal of Immunology·2023Open Access
Germline T cell receptor exchange results in physiological T cell development and function
Nature Communications·2023· 17 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Adam L. Burrack(26), Ingunn M. Stromnes(26), Zoe C. Schmiechen(23), Eduardo Cruz-Hinojoza(23), Grant H. Hickok(17), Jonah Z. Butler(15), Hezkiel A. Nanda(15), Steven S. Shen(15), Alexander K. Tsai(15), Cara-lin Lonetree(15), Nicholas J. Maurice(13), A. Rizzo(13), Michael J. Geuenich(12), Chengxin Yu(12), Madeline A. Ellefson(12), Audrey L. Hilk(12), Brandon M. Larsen(12), Kieran R. Campbell(12), Yingzheng Xu(5), Maria Firulyova(5)